Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 50:2243-2248, doi:10.1016/j.jacc.2007.08.033 (Published online 14 November 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Povsic, T. J.
Right arrow Articles by Peterson, E. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Povsic, T. J.
Right arrow Articles by Peterson, E. D.

Circulating Progenitor Cells Can Be Reliably Identified on the Basis of Aldehyde Dehydrogenase Activity

Thomas J. Povsic, MD, PhD*,*, Katherine L. Zavodni, BS*, Francine L. Kelly, BS*, Shoukang Zhu, PhD*, Pascal J. Goldschmidt-Clermont, MD, FACC{ddagger}, Chunming Dong, MD* and Eric D. Peterson, MD, MPH, FACC{dagger}

* Division of Cardiology, Duke University Medical Center, Durham, North Carolina
{dagger} Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
{ddagger} Miller School of Medicine, University of Miami, Miami, Florida.


Figure 1
View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 EPC Identification Based on ALDH Activity

A discrete group of cells, absent in the diethylaminobenzaldehyde (DEAB) control sample (left), with high aldehyde dehydrogenase (ALDH) activity and low side-scatter, is identified in the right lower quadrant (right). EPC = endogenous progenitor cell; FITC = fluorescein isothiocyanate.

 

Figure 2
View larger version (31K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Characterization of ALDHbr Cells

Aldehyde dehydrogenase-bright (ALDHbr) cells were subjected to staining for expression of select endogenous progenitor cell markers (n = 21). The purple column indicates the percentage of CD133+CD34+ cells also expressing elevated ALDH activity.

 

Figure 3
View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Correlation Between ALDHbr Cell Numbers and EPCs Expressing Specific Cell Surface Markers

Correlation of aldehyde dehydrogenase-bright (ALDHbr) cells with CD133+ cells (A), CD34+ cells (B), CD133+CD34+ cells (C), and vascular endothelial growth factor receptor (VEGFR)-2+CD34+ cells (D). Spearman correlation coefficients are shown. EPCs = endogenous progenitor cells; MNCs = mononuclear cells.

 

Figure 4
View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Correlation of ALDHbr Cell Number and Patient Age and Extent of CAD

Aldehyde dehydrogenase-bright (ALDHbr) cells are inversely correlated with patient age (n = 110; p < 0.01) and extent of coronary artery disease (CAD) (n = 110; p value for analysis of variance analysis and analysis for linear trend). MNCs = mononuclear cells.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement